Articles

Podcasts

Videos

Cardiology

Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...

The oral suspension for rivaroxaban prevents blood clots in patients aged ≥2 years with congenital heart disease following the Fontan procedure. 

FDA Approves Rivaroxaban To Treat, Prevent Blood Clots In Pediatric Patients 

The TPV system expands transcatheter therapy options for patients with congenital heart valve disease. 

FDA Approves Transcatheter Valve With Adaptive Prestent For Pulmonary Regurgitation

Data show the multivariable-adjusted HR for increase in seafood consumption of 1 oz per day and all-cause mortality was 0.84 and for CVD-related mortality was 0.89. 

Mercury Exposure From Seafood Not Significantly Linked to CVD, All-Cause Mortality 

Study data show for each $1,000 decrease in median household income, the number of TAVR procedures performed per 100,000 Medicare beneficiaries was 0.2% lower.

Low Socioeconomic Status Linked to Lower Rates of TAVR in Aortic Stenosis Treatment 

After 1 year, 37% of patients had died and 65% of patients were readmitted to the hospital.

Risks Remain for Heart Failure Patients Following Hospital Discharge

Young smokers in 2017 were more likely to have other comorbid conditions including hypertension, diabetes, and obesity.

Acute Myocardial Infarction Hospitalization Rate Decreasing for Young Smokers

The least selected attributes were food and medication restrictions and A1c lowering followed by risk of diabetic ketoacidosis, risk of genital infection, and the avoidance of severe hypoglycemia. 

Doctors Weigh Cardiovascular Risk Reduction Over Side Effects for Antihyperglycemic Agents

Epinephrine before defibrillation was associated with lower odds of survival to discharge, favorable neurological survival, and survival after acute resuscitation

Epinephrine Before Defibrillation In Cardiac Arrest Linked To Poor Outcomes 

In patients with advanced heart failure, the median NT-proBNP AUC for valsartan was 1.19 compared to an AUC of 1.08 for sacubitril/valsartan. 

Sacubitril/Valsartan, Valsartan Show No Difference in Reduction of NT-proBNP Levels 

The American College of Cardiology and American Heart Association guideline provides key highlights into the evaluation and diagnosis of adult patients with chest pain.


New Clinical Guideline Focuses Solely on Chest Pain Evaluation, Diagnosis 

The HCPLive heart failure page is a resource for medical news and expert insights on HF. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for heart disease, reduced and preserved ejection fraction, and more.